Literature DB >> 2679057

Insulin resistance of uremia.

S R Hager1.   

Abstract

Glucose intolerance is a nearly universal finding in patients with chronic renal failure and in animal models of uremia. The glucose intolerance results from impaired insulin-mediated glucose disposal by muscle, adipose, and liver tissue. Insulin binding by these tissues is not reduced. Rather, several defects exist in the postreceptor cascade of insulin action. Although impaired insulin-mediated glucose uptake and metabolism occur, the primary defect and causative agent are not established. The purpose of the present article is to review recent literature on the potential mechanisms underlying the insulin resistance of chronic renal failure.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2679057     DOI: 10.1016/s0272-6386(89)80201-x

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  8 in total

Review 1.  Etiology and management of dyslipidemia in children with chronic kidney disease and end-stage renal disease.

Authors:  Mona Khurana; Douglas M Silverstein
Journal:  Pediatr Nephrol       Date:  2015-03-24       Impact factor: 3.714

2.  Day-to-day variation of insulin requirements of patients with type 2 diabetes and end-stage renal disease undergoing maintenance hemodialysis.

Authors:  Eugene Sobngwi; Sostanie Enoru; Gloria Ashuntantang; Marcel Azabji-Kenfack; Mesmin Dehayem; Arnold Onana; Daniel Biwole; François Kaze; Jean-François Gautier; Jean-Claude Mbanya
Journal:  Diabetes Care       Date:  2010-03-09       Impact factor: 17.152

3.  Serum beta-endorphin in non-dialysed and haemodialysed patients with chronic renal failure.

Authors:  P Trelewicz; W Grzeszczak; R Drabczyk
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

4.  Protection of Renal Function with ACE Inhibitors: Experience with Benazepril.

Authors:  J C Aldigier; Y L Meur; P Brunel
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

Review 5.  Relationship between chronic kidney disease and metabolic syndrome: current perspectives.

Authors:  Khaled Nashar; Brent M Egan
Journal:  Diabetes Metab Syndr Obes       Date:  2014-09-18       Impact factor: 3.168

Review 6.  Management of diabetes mellitus in individuals with chronic kidney disease: therapeutic perspectives and glycemic control.

Authors:  Carolina C R Betônico; Silvia M O Titan; Maria Lúcia C Correa-Giannella; Márcia Nery; Márcia Queiroz
Journal:  Clinics (Sao Paulo)       Date:  2016-01       Impact factor: 2.365

7.  Extreme insulin resistance in a patient with diabetes ketoacidosis and acute myocardial infarction.

Authors:  Yin H Oo; Jocelyne G Karam; Christine A Resta
Journal:  Case Rep Endocrinol       Date:  2013-01-27

8.  Effect of Short-term Erythropoietin Therapy on Insulin Resistance and Serum Levels of Leptin and Neuropeptide Y in Hemodialysis Patients.

Authors:  Hamed M Osman; Osama A Khamis; Mohamed S Elfeky; Amani M El Amin Ali; Mostafa Y Abdelwahed
Journal:  Indian J Endocrinol Metab       Date:  2017 Sep-Oct
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.